Cite

HARVARD Citation

    Lei, M. et al. (2019). Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors. Journal of oncology pharmacy practice. pp. 1402-1411. [Online]. 
  
Back to record